ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2017; 24(3): 310-315


Ischemia modified albumin levels and its association with clinical follow-up in acute renal failure

Mehmet Uzun, Omercan Topaloglu, Yusuf Kurtulmus, Hakan Turkon, Can Duman, Burak Karakas, Harun Akar, Mehmet Tanrisev.



Abstract
Download PDF Cited by 0 ArticlesPost

Aim: In cases with acute ischemia, albumin’s binding capacity for transition metals decreases and the resulting albumin is defined as ischemia modified albumin (IMA). In this study, we aimed to investigate the relationship between IMA and clinical follow-up in patients with acute renal failure (ARF).
Material and Methods: Levels of IMA were measured in 51(23 male, 28 female) patients with ARF. Venous blood samples were drawn from patients for biochemical tests and put in plain tubes containing the gel.
Results: Mean age of male and female patients was 65.39±15.28 and 70.11±15.25, respectively. The IMA levels in 25.5% of the patients were within the normal range (400 ABSU) in 75.5% of the patients. The survival rates of patients in IMA

Key words: Acute Renal Failure; Ischemia Modified Albumin; Acute Kidney Injury.







Bibliomed Article Statistics

31
47
30
41
30
14
33
19
21
21
19
24
R
E
A
D
S

14

21

32

41

31

25

29

26

14

18

13

10
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.